299 related articles for article (PubMed ID: 19145073)
41. Progressive accumulation of lanthanum in the liver of normal and uremic rats.
Slatopolsky E; Liapis H; Finch J
Kidney Int; 2005 Dec; 68(6):2809-13. PubMed ID: 16316357
[TBL] [Abstract][Full Text] [Related]
42. Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.
Mizobuchi M; Ogata H; Hatamura I; Koiwa F; Saji F; Shiizaki K; Negi S; Kinugasa E; Ooshima A; Koshikawa S; Akizawa T
Nephrol Dial Transplant; 2006 Apr; 21(4):911-6. PubMed ID: 16384827
[TBL] [Abstract][Full Text] [Related]
43. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.
Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA
Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101
[TBL] [Abstract][Full Text] [Related]
44. Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
Inserra F; Basso N; Ferder M; Userpater M; Stella I; Paglia N; Inserra P; Tenembaum D; Ferder L
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):341-6. PubMed ID: 19574289
[TBL] [Abstract][Full Text] [Related]
45. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
[TBL] [Abstract][Full Text] [Related]
46. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
Yamada S; Taniguchi M; Tokumoto M; Toyonaga J; Fujisaki K; Suehiro T; Noguchi H; Iida M; Tsuruya K; Kitazono T
J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
[TBL] [Abstract][Full Text] [Related]
47. Cardiac and renal effects of atrasentan in combination with enalapril and paricalcitol in uremic rats.
Ritter C; Zhang S; Finch JL; Liapis H; Suarez E; Ferder L; Delmez J; Slatopolsky E
Kidney Blood Press Res; 2014; 39(4):340-52. PubMed ID: 25300759
[TBL] [Abstract][Full Text] [Related]
48. [Management of hyperphosphatemia ; phosphate-binder].
Yokoyama K
Clin Calcium; 2009 Feb; 19(2):205-12. PubMed ID: 19182360
[TBL] [Abstract][Full Text] [Related]
49. Clinical consequences and novel therapy of hyperphosphatemia: Lanthanum carbonate for dialysis patients.
Cozzolino M; Brancaccio D
Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):29-34. PubMed ID: 18221100
[TBL] [Abstract][Full Text] [Related]
50. Sevelamer therapy for pediatric end-stage renal disease.
Storms LE; Chicella MF; Dice JE
Pharmacotherapy; 2006 Mar; 26(3):410-3. PubMed ID: 16503722
[TBL] [Abstract][Full Text] [Related]
51. Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice.
Nikolov IG; Joki N; Nguyen-Khoa T; Guerrera IC; Maizel J; Benchitrit J; Machado dos Reis L; Edelman A; Lacour B; Jorgetti V; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2012 Feb; 27(2):505-13. PubMed ID: 21705467
[TBL] [Abstract][Full Text] [Related]
52. Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels.
Terai K; Nara H; Takakura K; Mizukami K; Sanagi M; Fukushima S; Fujimori A; Itoh H; Okada M
Br J Pharmacol; 2009 Apr; 156(8):1267-78. PubMed ID: 19302594
[TBL] [Abstract][Full Text] [Related]
53. Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
Izumi M; Morita S; Nishian Y; Miyamoto T; Kasumoto H; Oue M; Hori K; Kitamura R; Yamamoto S; Nakanishi T
Ren Fail; 2008; 30(10):952-8. PubMed ID: 19016145
[TBL] [Abstract][Full Text] [Related]
54. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
Song J; Meng L; Li S; Qu L; Li X
Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
[TBL] [Abstract][Full Text] [Related]
55. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.
Russo D; Miranda I; Ruocco C; Battaglia Y; Buonanno E; Manzi S; Russo L; Scafarto A; Andreucci VE
Kidney Int; 2007 Nov; 72(10):1255-61. PubMed ID: 17805238
[TBL] [Abstract][Full Text] [Related]
56. Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats.
Piotrkowski B; Koch OR; De Cavanagh EM; Fraga CG
Free Radic Res; 2009 Apr; 43(4):390-9. PubMed ID: 19296328
[TBL] [Abstract][Full Text] [Related]
57. Beneficial effects of Renin-Angiotensin system blockers on testicular steroidogenesis.
Alves-Pereira JL; Frantz ED; da Fonte Ramos C
J Urol; 2014 Dec; 192(6):1878-83. PubMed ID: 24880039
[TBL] [Abstract][Full Text] [Related]
58. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
59. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy.
Mathew S; Lund RJ; Strebeck F; Tustison KS; Geurs T; Hruska KA
J Am Soc Nephrol; 2007 Jan; 18(1):122-30. PubMed ID: 17182886
[TBL] [Abstract][Full Text] [Related]
60. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
